A phase I clinical trial of entinostat and lapatinib in patients with trastuzumab refractory HER2-positive metastatic breast cancer

Category Primary study
JournalCANCER RESEARCH
Year 2015
This article has no abstract
Epistemonikos ID: 51650b52917665bcd81fe353bd72a8aad75b6e0a
First added on: Feb 07, 2025